To compare the status of peripheral blood lymphocyte and CD4+ T cell subsets of refractory RA with healthy donors and whether low-dose IL2 could effectively induce remission of refractory RA by upregulating Treg cells. The gene discussed is CD4; the disease is rheumatoid arthritis.